Augmedix Announces Participation in Oppenheimer’s 33rd Annual Healthcare Conference
Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient medical documentation, announced that CEO Manny Krakaris and CFO Paul Ginocchio will present at the Oppenheimer 33rd Annual Healthcare Conference from March 13-15, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient medical documentation, announced that CEO Manny Krakaris and CFO Paul Ginocchio will present at the Oppenheimer 33rd Annual Healthcare Conference from March 13-15, 2023. They will host a live webcast on March 14 at 2:00 p.m. ET. The company's innovative solutions improve clinical workflows by converting physician-patient conversations into real-time medical notes, enhancing patient care and reducing clinician burnout. Interested investors can join the webcast or meet with management during the event.
Positive
- Participation in Oppenheimer 33rd Annual Healthcare Conference highlights company visibility and investor engagement.
- Live webcast presentation allows broader access to investor community, enhancing transparency.
Negative
- None.
Details
News Market Reaction – AUGX
The recorded move for AUGX in the trading session of this news was -1.16%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that Manny Krakaris, Chief Executive Officer, and Paul Ginocchio, Chief Financial Officer will attend and present at the Oppenheimer 33rd Annual Healthcare Conference taking place virtually on March 13 – 15, 2023.
Management will host a live webcast presentation at 2:00 p.m. ET on Tuesday, March 14, 2023, and will also conduct one-on-one investor meetings throughout the conference.
Details for the live webcast presentation are below.
| Date: | Tuesday, March 14 |
| Time: | 2:00 p.m. ET |
| Webcast: | https://wsw.com/webcast/oppenheimer27/augx/2795849 |
Attending investors interested in meeting with Augmedix management can contact their Oppenheimer representative. Investors can also contact the Augmedix IR team at investors@augmedix.com to learn more.
About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix’s products extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company’s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.
Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.